AWS, C++, Cloud computing, Containerization, Docker, Git, Github, Java Programming, Linux Operating system, MATLAB Programming, Python Programming, R-Shiny, SAS, Shell Scripting language, Tidyverse, Unix Operating system
Neurodegenerative diseases are one of the largest medical challenges of our time. Denali Therapeutics is a biotechnology company dedicated to developing breakthrough therapies for neurodegenerative diseases through our deep commitment to degeneration biology and principles of translational medicine. Denali is founded on the collaboration of leading scientists, industry experts, and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.
The Opportunity
Denali is seeking a highly motivated individual with strong statistical methodology knowledge, R programming expertise and problem-solving skills to join us for a summer Biostatistician internship in the Biometrics group at Denali Therapeutics. The successful candidate will support impactful projects related to reviewing literature, analyzing real-world data, developing new statistical methodologies and running simulations with guidance from a mentor. The intern will gain an in-depth understanding of drug development, experience working in a fast-moving industry environment, and subject domain knowledge in the field of neurodegeneration.
Responsibilities
Requirements
Denali is committed to its core company value of unity by creating a diverse and inclusive environment. We are proud to be an equal opportunity employer and do not discriminate against any employee or applicant for employment because of race, color, sex, age, national origin, religion, sexual orientation, gender identity and/or expression, status as a veteran, basis of disability, or any other federal, state or local protected class.
Job Facts
Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families. Our scientific approach is based on three core principles: rigorous assessment of genetic targets, engineering brain delivery, and using biomarkers to guide development.
South San Francisco, CA, USA
4-6 year